Glen A. Taylor - Aug 27, 2024 Form 4 Insider Report for Envoy Medical, Inc. (COCH)

Role: Director, 10%+ Owner
Signature: /s/ Andrew Nick as Attorney-in-Fact for Glen A. Taylor pursuant to a Power of Attorney previously filed
Stock symbol: COCH
Transactions as of: Aug 27, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/29/2024, 04:06 PM
Previous filing: Jul 24, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	COCH	Class A Common Stock						2.95M	Aug 27, 2024	Direct
holding	COCH	Class A Common Stock						2.53M	Aug 27, 2024	By Taylor Sports Group	F1
holding	COCH	Class A Common Stock						4.81M	Aug 27, 2024	By GAT Funding, LLC	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	COCH	Warrant (right to buy)	Award	$0	+500K		$0.00	500K	Aug 27, 2024	Class A Common Stock	500K	$2.97	GAT Funding, LLC	F2, F4
holding	COCH	Series A Preferred Stock						1M	Aug 27, 2024	Class A Common Stock	870K	$11.50	GAT Funding, LLC	F2, F3
holding	COCH	Warrant (right to buy)						500K	Aug 27, 2024	Class A Common Stock	500K	$1.24	GAT Funding, LLC	F2
holding	COCH	Warrant (right to buy)						250K	Aug 27, 2024	Class A Common Stock	250K	$3.04	GAT Funding, LLC	F2
holding	COCH	Warrant (right to buy)						250K	Aug 27, 2024	Class A Common Stock	250K	$2.25	GAT Funding, LLC	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person is the owner and chairman of Taylor Sports Group.
F2	GAT Funding, LLC is an entity controlled by the Reporting Person.
F3	Fully exercisable and there is no expiration date.
F4	In connection with the Issuer's draw under the promissory note issued on August 27, 2024 to GAT Funding, LLC, this warrant was issued as a commitment fee, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on August 28, 2024.